{"university":{"openalex_id":"I181343428","name":"University of Zagreb"},"topic":"age-crosslink-breakers","total_matching":3,"offset":0,"next_offset":null,"records":[{"doi":"https://doi.org/10.3390/ijms22115973","title":"The Mystery of Diabetic Cardiomyopathy: From Early Concepts and Underlying Mechanisms to Novel Therapeutic Possibilities","source_url":"https://doi.org/10.3390/ijms22115973","source_name":"International Journal of Molecular Sciences","cited_by_count":62,"is_open_access":true,"openalex_work_id":"W3166606347","publication_date":"2021-06-01","publication_year":2021,"university_research_work_topics":[{"topic_slug":"age-crosslink-breakers"}]},{"doi":"https://doi.org/10.20944/preprints202512.1682.v1","title":"Mushroom-Derived Compounds as Inhibitors of Advanced Glycation End-Products","source_url":"https://doi.org/10.20944/preprints202512.1682.v1","source_name":"Preprints.org","cited_by_count":0,"is_open_access":true,"openalex_work_id":"W4417477509","publication_date":"2025-12-18","publication_year":2025,"university_research_work_topics":[{"topic_slug":"age-crosslink-breakers"}]},{"doi":"https://doi.org/10.3390/app16020617","title":"Mushroom-Derived Compounds as Inhibitors of Advanced Glycation End-Products","source_url":"https://doi.org/10.3390/app16020617","source_name":"Applied Sciences","cited_by_count":1,"is_open_access":true,"openalex_work_id":"W7118657163","publication_date":"2026-01-07","publication_year":2026,"university_research_work_topics":[{"topic_slug":"age-crosslink-breakers"}]}],"automation_disclosure":"Generated automatically from cited source metadata. No scientist, clinician, researcher, editor, or human reviewer evaluates this publication before release."}